Filing summary
Important identity and period note: The supplied filing is Spherix Incorporated and subsidiaries’ Form 10-Q for the quarter ended September 30, 2014, signed November 13, 2014. It is not a filing for Dominari Holdings Inc.; the company and period should be verified before relying on this summary.
Business context and reporting period
Spherix described itself as an intellectual-property company seeking to monetize patent portfolios through licensing, commercialization, settlements and litigation. The filing reports unaudited results for the three and nine months ended September 30, 2014, with comparisons to 2013.
Key financial metrics
| Metric | Q3 2014 | Nine months 2014 |
|---|---|---|
| Revenue | $2,000 | $9,000 |
| Operating expenses | $5.164 million | $24.765 million |
| Operating loss | $5.162 million | $24.756 million |
| Net loss | $5.144 million | $24.675 million |
| Net loss per share, basic and diluted | $0.18 | $1.47 |
| Cash used in operating activities | Not stated for quarter | $4.767 million |
Revenue was nominal, so the filing does not provide a meaningful operating margin. At September 30, cash and cash equivalents were $5.550 million, working capital was approximately $5.4 million, total current assets were $5.618 million and current liabilities were $185,000. Total liabilities were $185,000; the balance sheet also showed $5.935 million of redeemable Series I preferred stock outside stockholders’ equity. No debt balance is reported. Total assets were $64.841 million, including $57.481 million of patent portfolios.
Cash increased $2.425 million during the first nine months, from $3.125 million to $5.550 million. Financing activities provided $8.196 million, including $3.874 million net from common-stock and warrant issuance and $18.387 million net from preferred-stock issuance, offset in part by $14.065 million of Series I redemptions. Investing activities used $1.004 million, including payment of $1.0 million in accrued patent costs.
Material changes versus comparable periods
- Q3 operating loss narrowed from $9.317 million in 2013 to $5.162 million in 2014; net loss narrowed from $9.280 million to $5.144 million. Management attributed the improvement mainly to lower stock-based compensation and professional expenses.
- For the first nine months, operating loss increased from $11.174 million to $24.756 million and net loss increased from $13.784 million to $24.675 million. Higher stock compensation, patent amortization and professional fees contributed; the prior-year period also included a $2.610 million warrant fair-value expense.
- Patent amortization was $7.354 million for the first nine months of 2014, versus $134,000 in 2013. Patent portfolio carrying value declined from $64.835 million at year-end 2013 to $57.481 million.
- Common shares outstanding rose substantially, from 3.770 million at December 31, 2013 to 28.599 million at September 30, 2014. Series J preferred financing proceeds were followed by conversion of all 10 million Series J shares into common stock.
Outlook, risks, contingencies and unusual items
- Going concern: Management stated there is substantial doubt about Spherix’s ability to continue as a going concern. It said existing liquidity would not fund operations and other requirements for the foreseeable future and that additional financing and/or revenue growth would be needed; future financing may not be available on favorable terms or at all.
- Preferred-stock obligations: After the June 2014 $14.1 million Series I redemption, the filing said approximately $1.0 million could be due by June 2015 and $5.0 million by December 31, 2015 if the remaining preferred stock is not converted. The preferred stock is secured by the Rockstar patent portfolio under specified default terms.
- Unusual expenses and cash uses: A director’s resignation triggered accelerated vesting of 837,500 options and a $4.3 million stock-compensation charge. Spherix also recorded a $654,000 non-cash registration-rights penalty and paid a $266,000 settlement related to its office lease dispute.
- Patent litigation: The company’s monetization strategy depends on contested intellectual-property rights. It warned that adverse validity or infringement decisions, inter partes reviews, fee-shifting and legal costs could impair patent value, increase expenses or exceed recoveries. Multiple patent suits and counterclaims were pending; management said it had not recorded a loss provision for the counterclaims.
- Controls: Management concluded disclosure controls and procedures were not effective as of September 30, 2014 because of a lack of segregation of duties. It described remediation plans but said implementation was constrained by financial and staffing resources.
- Outlook: No quantified revenue, earnings or cash-flow guidance was provided.
Most important facts for investors to verify
- Confirm the filing belongs to the intended issuer: this document identifies Spherix Incorporated, not Dominari Holdings Inc.
- Review the going-concern disclosure, cash runway and assumptions about additional financing and patent monetization.
- Verify the remaining Series I preferred redemption schedule, security rights and any conversions or payments after September 30, 2014.
- Assess dilution from the substantial increase in common shares and outstanding options, warrants and convertible securities.
- Check subsequent outcomes in the disclosed patent cases, counterclaims and inter partes review requests, as well as any effects on patent values or litigation costs.
- Track remediation of the disclosed segregation-of-duties weakness and whether controls were later found effective.